Countries North America

Merck Reports Strong 2024 Growth with €21.2 Billion in Sales, Projects Continued Expansion in 2025

Merck, a leading science and technology company, has delivered profitable growth in fiscal year 2024, demonstrating resilience and strategic execution acro...

 March 07, 2025 | Company results

Suvoda Launches AI Assistant ‘Sofia’ to Enhance Clinical Trial Efficiency

 Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...

 March 06, 2025 | News

Frazier Life Sciences Launches Callio Therapeutics with $187M Series A to Advance Multi-Payload ADCs

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from&nb...

 March 05, 2025 | News

Celltrion Secures FDA Approval for STOBOCLO® and OSENVELT® as Biosimilars to PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA®&nbs...

 March 05, 2025 | News

Elis Expands Cleanroom Solutions with Acquisition of BeMicron

Elis, the international multi-service provider for cleanroom, workwear,  hygiene and facility services solutions, today announces the acquisition of 1...

 March 05, 2025 | News

Elsevier Expands ClinicalKey AI with EHR and HIT Integrations to Enhance Clinician Workflows

Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company's leading generative ...

 March 04, 2025 | News

MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform

MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...

 March 04, 2025 | News

SmithRx Expands Connect 360 Autoimmune Program Adding Stelara Biosimilars and Partnering with Costco Specialty Pharmacy

SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM),  announced a major expansion to its Connect 360 Autoimmune Program, ...

 March 03, 2025 | News

Bambusa Therapeutics Initiates First Clinical Trial for BBT001 a Bispecific Antibody Targeting Atopic Dermatitis

Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopi...

 March 03, 2025 | News

Metabolon Expands Multiomics Biomarker Discovery with New Integrated Bioinformatics Capabilities

 Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic dev...

 February 28, 2025 | News

Ubie and Nucleus Genomics Partner to Expand Access to Genetic Screening and Early Disease Detection

Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all ages The partnership combine...

 February 28, 2025 | News

Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...

 February 27, 2025 | News

HBM Alpha Therapeutics Secures $395M Licensing Deal to Advance CRH-Targeting Therapy

HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaborati...

 February 26, 2025 | News

Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash

 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science,  announced that the company has en...

 February 25, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close